Facing pressure across Washington, drug industry courts pro-business Democrats
Progressives, the White House, and even Capitol Hill conservatives have dialed up the pressure on pharma. This week, drug companies are aggressively courting a coalition of pro-business Democrats.
WASHINGTON — Facing hostility from nearly every corner of Capitol Hill, drug makers have spent recent weeks aggressively courting a group of business-friendly Democrats.
PhRMA and BIO, the two major drug industry trade groups, met last week with the New Democrat Coalition, according to multiple Democratic aides. The group, which includes more than 100 members and describes itself as politically moderate and “pro-growth,” has also scheduled meetings with the drug companies Pfizer and Genentech, as well as the California Life Sciences Association (CSLA), which represents drug makers including AbbVie and
